RECRUITING

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Description

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Conditions

Study Overview

Study Details

Study overview

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Condition
Bladder Cancer
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Abramson Cancer Center, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 years or older;
  • * completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders
  • * Age 18 years or older;
  • * experience with the delivery of BCG delivery for more than 2 years
  • * Age 18 years or older;
  • * diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy
  • * inability to provide informed consent
  • * inability to undergo catheterization (i.e. - history of urethral stricture)
  • * inability to receive BCG therapy (i.e. - previous reaction with BCG)
  • * no access to mobile phone
  • * inability to respond to written conversations in English

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pennsylvania,

Study Record Dates

2026-09-05